[1]
“THE USE OF ANTIBODIES AS A THERAPEUTIC MEASURE IN CREUTZFELDT-JAKOB DISEASE: AN INTEGRATIVE REVIEW”, IJHS- PDVS, vol. 5, no. 1, pp. 160–171, Jun. 2025, doi: 10.31692/2764-3433.v5i1.295.